Jane Lebkowski News Today

Researchers pursue experimental treatments for dry age-related macular degeneration that replace or replenish dead cells in the retina at the back of the eye.

Continuing the Alzheimer’s and Neurodegenerative Diseases track in the Rejuvenation Biotechnology Conference, Jane Lebkowski, President of R&D, Asterias Biotherapeutics Inc. discussed her group’s work on the development of pluripotent stem cell derived oligodendrocyte progenitor cells for the treatment of spinal …